<SEC-DOCUMENT>0000784199-16-000239.txt : 20160318
<SEC-HEADER>0000784199-16-000239.hdr.sgml : 20160318
<ACCEPTANCE-DATETIME>20160318163914
ACCESSION NUMBER:		0000784199-16-000239
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20160318
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160318
DATE AS OF CHANGE:		20160318

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRYOLIFE INC
		CENTRAL INDEX KEY:			0000784199
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				592417093
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13165
		FILM NUMBER:		161516521

	BUSINESS ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
		BUSINESS PHONE:		7704193355

	MAIL ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>c199-20160318x8k.htm
<DESCRIPTION>8-K
<TEXT>
<!--HTML document created with Certent Powered by Crossfire 5.17.1.24-->
<!--Created on: 3/18/2016 4:37:11 PM-->
<html>
	<head>
		<title>
			8K Project Pluto  3-17-16
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;">
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:478.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;line-height:normal;font-family:Calibri;height:1.00pt;overflow:hidden;font-size:0pt;">
						<a name="_GoBack"></a><font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:478.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;overflow: hidden;font-size:0pt;">
						<a name="_DV_M0"></a><font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:478.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 14pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:14pt;">UNITED STATES</font><font style="display: inline;font-family:Times New Roman;font-size:14pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 14pt">
			<a name="_DV_M1"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:14pt;">SECURITIES AND EXCHANGE COMMISSION</font><br /><font style="display: inline;font-family:Times New Roman;font-size:14pt;"></font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:13pt;">Washington, D.C. &nbsp;20549</font><br /><font style="display: inline;font-family:Times New Roman;font-size:14pt;"></font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:14pt;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:126.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:12pt 0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 14pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:14pt;">FORM 8-K</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M2"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">CURRENT REPORT</font><br /><font style="display: inline;font-family:Times New Roman;font-size:12pt;"></font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">PURSUANT TO SECTION 13 OR 15(d) OF THE</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M3"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">SECURITIES EXCHANGE ACT OF 1934</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 10pt">
			<a name="_DV_M4"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Date of Report (Date of earliest event reported):&nbsp; </font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">March</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">1</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">8</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">, 2016</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M5"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">_______________________</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 18pt">
			<a name="_DV_M6"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:18pt;">CRYOLIFE, INC.</font><font style="display: inline;font-family:Times New Roman;font-size:18pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 10pt">
			<a name="_DV_M7"></a><font style="display: inline;font-family:Times New Roman;font-size:10pt;">(Exact name of registrant as specified in its charter)</font><br /><font style="display: inline;font-family:Times New Roman;font-size:10pt;"></font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">_________________________</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;overflow: hidden;font-size:0pt;">
						<a name="_DV_M8"></a><font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;overflow: hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;overflow: hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;">Florida</font><font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;">1-13165</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;">59-2417093</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-family:Times New Roman;font-size:9pt;">(State or Other Jurisdiction</font><br /><font style="display: inline;font-family:Times New Roman;font-size:9pt;">of Incorporation)</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-family:Times New Roman;font-size:9pt;">(Commission File Number)</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-family:Times New Roman;font-size:9pt;">(IRS Employer</font></p>
					<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-family:Times New Roman;font-size:9pt;">Identification No.)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">1655 Roberts Boulevard, N.W., </font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">Kennesaw, </font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">Georgia &nbsp;30144</font><br /><font style="display: inline;font-family:Times New Roman;font-size:12pt;"></font><font style="display: inline;font-family:Times New Roman;font-size:9pt;">(Address of principal executive office) (zip code)</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 11pt">
			<a name="_DV_M9"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;">Registrant's telephone number, including area code: (770) 419-3355</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 9pt">
			<a name="_DV_M10"></a><font style="display: inline;font-family:Times New Roman;font-size:9pt;">_____________________________________________________________ </font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 9pt">
			<a name="_DV_M11"></a><font style="display: inline;font-family:Times New Roman;font-size:9pt;">(Former name or former address, if changed since last report)</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 10pt">
			<a name="_DV_M12"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">_________________________</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M13"></a><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 72pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:MS Mincho;font-size:12pt;">&#x2610;</font><a name="_DV_M14"></a><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </font>
		</p>
		<p style="margin:0pt 0pt 0pt 90pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 72pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M15"></a><font style="display: inline;font-family:MS Mincho;font-size:12pt;">&#x2610;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </font>
		</p>
		<p style="margin:0pt 0pt 0pt 90pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 72pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M16"></a><font style="display: inline;font-family:MS Mincho;font-size:12pt;">&#x2610;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </font>
		</p>
		<p style="margin:0pt 0pt 0pt 90pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 72pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:MS Mincho;font-size:12pt;">&#x2610;</font><a name="_DV_M17"></a><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt 0pt 0pt 72pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;;font-size: 12pt"><font style="display: inline;font-family:Times New Roman;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt">
			<a name="S110762357"></a><font style="display: inline;font-weight:bold;">Item 8.01 Other Events.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 1.5pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">On March 1</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">8</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">, 2016, </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">CryoLife, Inc.</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">, a </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Florida</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> corporation (the &#x201C;Company&#x201D;), issued a</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> press release </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">announcing</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> sale of </font><a name="T0"></a><font style="display: inline;font-family:Times New Roman;font-size:12pt;">the Company&#x2019;s ProCol Vascular Bioprosthesis (&#x201C;ProCol&#x201D;) distribution rights and purchase option </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">to </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">LeMaitre Vascular, Inc</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">.&nbsp; </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">A copy of the</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> press release</font><a name="T1"></a><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:right;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">Item 9.01 </font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">Financial Statements and Exhibits.</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">(d)</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;;font-size: 12pt;font-family:Calibri;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;"></font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">Exhibits</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;"> &nbsp; </font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:117.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;line-height:normal;font-family:Calibri;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;font-family:Calibri;line-height:115%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:117.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Exhibit Number</font></p>
				</td>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Description</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:117.90pt;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">99.1*</font></p>
				</td>
				<td valign="top" style="width:239.40pt;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">Press release dated March 1</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">8</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">, 2016</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:normal;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">*This exhibit is furnished, not filed. </font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M30"></a><a name="_DV_M38"></a><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;line-height:100%;text-indent: -108pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Calibri;line-height:115%;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt 0pt 10pt;font-family:Calibri;line-height:115%;;font-size: 12pt"><font style="display: inline;font-family:Times New Roman;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:right;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:right;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">SIGNATURES</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M39"></a><br /><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, CryoLife, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;line-height:normal;font-family:Calibri;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;font-family:Calibri;line-height:115%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">CRYOLIFE, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">Date:&nbsp; </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">March 18</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">, 2016</font></p>
				</td>
				<td valign="top" style="width:46.10pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">By:</font></p>
				</td>
				<td valign="top" style="width:193.30pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">/s/ D. Ashley Lee</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:46.10pt;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">Name:</font></p>
				</td>
				<td valign="top" style="width:193.30pt;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">D. Ashley Lee</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:46.10pt;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">Title:</font></p>
				</td>
				<td valign="top" style="width:193.30pt;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">Exe</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">cutive Vice President, Chief </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Operating Officer and Chief Financial Officer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:normal;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>c199-20160318ex9917e71bf.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--HTML document created with Certent Powered by Crossfire 5.17.1.24-->
<!--Created on: 3/18/2016 4:37:16 PM-->
<html>
	<head>
		<title>
			8K Project Pluto Exh 991  3-17-16
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-size:11pt;">Exhibit 99.1</font>

		</p>

</div>
		<p style="margin:0pt;line-height:150%;text-align:left;border-bottom:1pt none #D9D9D9 ;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M0"></a><a name="_GoBack"></a><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:left;border-top:1pt none #D9D9D9 ;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-style:italic;font-size:12pt;">FOR IMMEDIATE RELEASE </font>
		</p>
		<p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;">Contacts:</font>
		</p>
		<p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:212.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden">
						<font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;"></font></p>
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 12pt">
						<font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Phone: 770-419-3355</font></p>
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:260.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt 0pt 0pt 17.1pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
					<p style="margin:0pt 0pt 0pt 17.1pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
					<p style="margin:0pt 0pt 0pt 17.1pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
					<p style="margin:0pt 0pt 0pt 17.1pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:212.40pt;height:12.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">CryoLife </font><font style="display: inline;font-weight:bold;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;"></font><font style="display: inline;"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p>
				</td>
				<td valign="top" style="width:260.40pt;height:12.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">The Ruth Group</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:212.40pt;height:17.80pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">D. Ashley Lee</font></p>
				</td>
				<td valign="top" style="width:260.40pt;height:17.80pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Nick Laudico / Zack Kubow</font></p>
				</td>
			</tr>
			<tr>
				<td rowspan="2" valign="top" style="width:212.40pt;height:13.90pt;padding:0pt 6.5pt;">
					<p style="margin:0pt 44.1pt 0pt 0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Executive Vice President, Chief Financial Officer and Chief Operating Officer</font></p>
				</td>
				<td valign="top" style="width:260.40pt;height:13.90pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">646-536-7030 / 7020</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:260.40pt;height:13.85pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;text-decoration:underline;">nlaudico@theruthgroup.com</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:212.40pt;height:17.80pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Phone: 770-419-3355</font></p>
				</td>
				<td valign="top" style="width:260.40pt;height:17.80pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;text-decoration:underline;">zkubow@theruthgroup.com</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;text-align:center;font-family:Times New Roman;font-size: 14pt">
			<a name="OLE_LINK1"></a><font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;text-transform:none;font-size:14pt;">CryoLife Announces Sale of ProCol</font><font style="display: inline;font-size:7pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;text-transform:none;font-size:14pt;"> Distribution Rights and Purchase Option to LeMaitre Vascular, Inc.</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;text-align:center;font-family:Times New Roman;font-size: 14pt">
			<font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 14pt">
			<font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M6"></a><font style="display: inline;font-weight:bold;color:#000000;">ATLANTA, GA&#x2026;(</font><font style="display: inline;font-weight:bold;color:#000000;">March 18</font><font style="display: inline;font-weight:bold;color:#000000;">, 2016)&#x2026;CryoLife, Inc. (NYSE: CRY), </font><font style="display: inline;color:#000000;">a leading medical device and tissue processing company focused on cardiac surgery, </font><font style="display: inline;">announced today that </font><font style="display: inline;">LeMaitre Vascular, Inc. (Nasdaq: LMAT) has acquired CryoLife&#x2019;s ProCol Vascular Bioprosthesis (&#x201C;ProCol&#x201D;) distribution rights and purchase option and has exercised that option </font><font style="display: inline;">to acquire ProCol from Hancock Jaffe Laboratories Inc. (&#x201C;Hancock Jaffe&#x201D;)</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">J. Patrick Mackin, Chairman, President, and Chief Executive Officer of CryoLife, said, &#x201C;The sale of ProCol builds on our strategy to sharpen our commercial focus.&nbsp;&nbsp;The recent divesture of HeRO</font><font style="display: inline;font-size:6pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;"> Graft and now ProCol allows our sales team to raise the profile of our best-in-class&nbsp;&nbsp;On-X mechanical valve technology and our compl</font><font style="display: inline;">e</font><font style="display: inline;">mentary cardiac surgery products and tissue preservations services.&nbsp;&nbsp;We remain confident that the recent doubling in size of our sales force and the streamlining of our product offerings will enhance of our growth trajectory and operating leverage.&#x201D;&nbsp; </font>
		</p>
		<p style="margin:15pt 0pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Mr. Mackin added, &#x201C;We believe this transaction represents a positive opportunity for both companies.&nbsp;&nbsp;ProCol is a unique product within the dialysis continuum of care for those patients who had a failed synthetic graft.&nbsp;&nbsp;LeMaitre has a complementary portfolio of vascular access and dialysis related products, with corresponding customer relationships, putting them in a strong position to broaden ProCol access for patients undergoing hemodialysis.&#x201D;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Under the terms of the agreements, CryoLife will receive approximately $2.0 million for all of its ProCol related assets, including inventory, customer lists, related marketing assets, and its purchase option, as well as for settlement of all amounts due to CryoLife from Hancock Jaffe.&nbsp;&nbsp;For the year ended December 31, 2015, CryoLife's ProCol revenue was $1.3 million.</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;">D. Ashley Lee, Executive Vice President, Chief Operating Officer, and Chief Financial Officer of CryoLife, said, &#x201C;The sale of our ProCol distribution rights and purchase option will not affect our previously issued revenue and non-GAAP earnings guidance.&nbsp;&nbsp;&nbsp;As with the proceeds from the sale of our HeRO Graft product line, we currently expect to utilize the cash proceeds from this sale for general corporate purposes and debt repayment.&#x201D;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;font-size:12pt;">About CryoLife</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac surgical procedures.&nbsp;&nbsp;CryoLife markets and sells products in more than 80 countries worldwide.&nbsp;&nbsp;For additional information about CryoLife, visit our website, </font><font style="display: inline;">www.cryolife.com</font><font style="display: inline;color:#000000;">.</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-style:italic;color:#000000;">Statements made in this press release that look forward in time or that express management's beliefs, expectations, or hopes are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.&nbsp; Such forward-looking statements reflect the views of management at the time such statements are made.&nbsp; These statements include those regarding expanded sales opportunities for CryoLife&#x2019;s products, CryoLife&#x2019;s enhanced growth trajectory and operating leverage and the expected payments to CryoLife in connection with our sale of our ProCol distribution rights and purchase option to LeMaitre Vascular, Inc.&nbsp;&nbsp;These forward-looking statements are subject to a number of risks, uncertainties, estimates, and assumptions that may cause actual results to differ materially from current expectations. These risks and uncertainties include that the expected sales opportunities for CryoLife&#x2019;s products and enhanced growth trajectory and operating leverage may not materialize or may diminish due to factors beyond our control, or that we may not realize the expected benefits from the sale of our ProCol distribution rights and purchase option to LeMaitre Vascular, Inc.&nbsp; These risks and uncertainties include the risk factors detailed in our Securities and Exchange Commission filings, including our Form 10-K for the year ended&nbsp;December 31, 2015&nbsp;and our subsequent filings with the SEC. CryoLife does not undertake to update its forward-looking statements.</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
